A 36-year-old woman with recurrent pneumothorax and no clear risk factors is found to have a rare inherited syndrome, diagnosed only through genetic testing.

Here, we identify formyl-peptide receptor type 2 (FPR2) as a therapeutic target to treat heart and lung dysfunction associated with inflammatory arthritis. Arthritic mice on high levels of dietary ...

Moleculin Biotech, Inc. announced promising results from their Phase 1B/2 trial of Annamycin for treating soft tissue sarcoma lung metastases, showing a robust clinical benefit rate of 59.4% among ...

In doing so, it has also identified a way to reverse that damage and restore lung function. We already know that exposure to air pollution is bad for us, and it’s particularly damaging for our ...

A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its developer calls a clinical first.

The replicate confirmatory KALOS and LOGOS trials evaluated BGF in participants with severe asthma inadequately controlled with standard of care.

In a phase 4 trial, dupilumab effectively reduces airway inflammation and mucus plugging, improving lung function and asthma control in patients with moderate to severe type 2 asthma.

Between a group of carpenters and an age-, sex- and height-matched group of university employees, carpenters had worse average lung function values, according to results published in BMC Pulmonary ...

Continued use of outdated race-specific equations while diagnosing children with asthma symptoms limits the identification of reduced lung function in Black children.

Findings showed treatment with nerandomilast led to a significant improvement in lung function compared with placebo. Topline data were announced from a phase 3 trial evaluating nerandomilast, an ...

Edgardo S. Santos, MD, FACP, FASCO, discussed the barriers to precision medicine in lung cancer treatment, including patient concerns about technology understanding and insurance coverage, as well ...